| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $586M | — | $490M | — | 19.7% |
| Op. Income | $78M | — | $70M | — | 12.3% |
| Gross Margin | 59.8% | — | 62.2% | — | -2.3pp |
| Net Margin | 4.8% | — | -47.3% | — | 52.1pp |
| EPS (Diluted) | $0.00 | — | $-0.87 | — | 100.0% |
| Free Cash Flow | -$115M | — | -$294M | — | 61.0% |
| Item | Amount |
|---|---|
| REVENUE | $586M |
| Cost of Revenue | $236M |
| GROSS PROFIT | $351M |
| R&D Expenses | $184M |
| Selling & Marketing | $0 |
| General & Administrative | $91M |
| SG&A Expenses | $91M |
| Other Expenses | -$3M |
| Operating Expenses | $273M |
| Cost & Expenses | $508M |
| OPERATING INCOME | $78M |
| Interest Income | $198M |
| Interest Expense | $149M |
| Other Income/Expenses | $58M |
| INCOME BEFORE TAX | $136M |
| Income Tax Expense | $108M |
| Net Income from Continuing Ops | $28M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $28M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $28M |
| D&A | $0 |
| EBIT | $78M |
| EBITDA | $78M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $586M |
| Cost of Revenue | $236M |
| GROSS PROFIT | $351M |
| R&D Expenses | $184M |
| Selling & Marketing | $0 |
| General & Administrative | $91M |
| SG&A Expenses | $91M |
| Other Expenses | -$3M |
| Operating Expenses | $273M |
| Cost & Expenses | $508M |
| OPERATING INCOME | $78M |
| Interest Income | $198M |
| Interest Expense | $149M |
| Other Income/Expenses | $58M |
| INCOME BEFORE TAX | $136M |
| Income Tax Expense | $108M |
| Net Income from Continuing Ops | $28M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $28M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $28M |
| D&A | $0 |
| EBIT | $78M |
| EBITDA | $78M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $28M |
| Depreciation & Amortization | $38M |
| Stock-Based Compensation | $17M |
| Deferred Income Tax | $108M |
| Other Non-Cash Items | -$124M |
| Change in Working Capital | -$118M |
| OPERATING CASH FLOW | -$50M |
| Capital Expenditure | -$64M |
| Acquisitions (Net) | -$14M |
| Purchases of Investments | -$32M |
| Sales/Maturities of Investments | $6M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$104M |
| Net Debt Issuance | $202M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$10M |
| NET CASH FROM FINANCING | $271M |
| FREE CASH FLOW | -$115M |
| Net Change in Cash | $121M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $172M |
| Short-Term Investments | $0 |
| Net Receivables | $70M |
| Inventory | $220M |
| Other Current Assets | $112M |
| TOTAL CURRENT ASSETS | $574M |
| PP&E (Net) | $356M |
| Goodwill | $13M |
| Intangible Assets | $82M |
| Long-Term Investments | $0 |
| Tax Assets | $192M |
| Other Non-Current Assets | $270M |
| TOTAL NON-CURRENT ASSETS | $913M |
| TOTAL ASSETS | $1.5B |
| Account Payables | $126M |
| Short-Term Debt | $37M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $128M |
| TOTAL CURRENT LIABILITIES | $304M |
| Long-Term Debt | $1.3B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $8M |
| Other Non-Current Liabilities | $59M |
| TOTAL NON-CURRENT LIABILITIES | $1.5B |
| TOTAL LIABILITIES | $1.8B |
| Common Stock | $3M |
| Additional Paid-In Capital | $2.1B |
| Retained Earnings | -$2.4B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $17M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | -$284M |
| Minority Interest | $0 |
| TOTAL EQUITY | -$284M |
| TOTAL LIABILITIES & EQUITY | $1.5B |
| Total Debt | $1.4B |
| Net Debt | $1.3B |
